BCTX

BriaCell Therapeutics Corporation
7.06
0.23 (3.37%)
Company Name Stock Ticker Symbol Market Type
BriaCell Therapeutics Corporation BCTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.23 3.37% 7.06 15:37:02
Open Price Low Price High Price Close Price Prev Close
6.83 6.83 7.25 6.83
more quote information »

Recent News

Date Time Source Heading
1/24/202309:07GLOBEBriaCell CEO Letter to Shareholders
1/23/202308:41GLOBEBriaCell to Investigate Alleged Illegal Trading of Public..
1/18/202308:47GLOBEBriaCell Announces Positive End of Phase II Meeting with the..
1/10/202309:00GLOBEBriaCell Announces New Patent Issuance, Bria-OTS™ IND Timing..
12/08/202209:25GLOBEBriaCell Announces Positive Clinical and Quality of Life..
11/30/202218:24BWBioStrand, la filiale d'IPA, et BriaCell, annoncent un..
11/30/202208:04BWIPA’s Subsidiary BioStrand and BriaCell Announce Artificial..
11/10/202209:00GLOBEBriaCell Reports Positive Breast Cancer Efficacy Data with..
10/21/202209:00GLOBEBriaCell Announces Successful Completion of Phase I Portion..
10/12/202209:00GLOBEBriaCell Announces New Clinical Trial Site to Bring Novel..
9/28/202209:15GLOBEBriaCell to Present New Clinical Data at the 2022 San..
9/14/202209:20GLOBEBriaCell Partners with Caris Life Sciences® to Expand..
9/07/202209:25GLOBEBriaCell Announces Presentation at the 2022 Society for..
8/04/202209:00GLOBEBriaCell Secures License for a Promising Novel Anti-Cancer..
7/05/202209:00GLOBEBriaCell Partners with Waisman Biomanufacturing to..
6/29/202209:00GLOBEBriaCell Enters Research Agreement to Identify Novel Targets..
6/24/202209:00GLOBEBriaCell Anti-Cancer Technology Published in Leading Cancer..
5/18/202209:15GLOBEBriaCell Adds Additional Clinical Sites to Broaden Patient..
4/13/202208:00GLOBEBriaCell Receives FDA Fast Track Approval for Targeted..
4/12/202216:30GLOBEBriaCell Presents Development Details of Bria-OTS™ Platform..
4/07/202208:30GLOBEBriaCell advances preparatory work for new Bria-OTS™ breast..
2/28/202208:00GLOBEBriaCell Adds Two Clinical Trial Sites to Accelerate Patient..
2/23/202208:00GLOBEBriaCell Appoints Leading Immunologist Dr. Alexander Kharazi..
2/10/202209:34SEEKBriaCell selected to present at upcoming medical event;..
2/10/202208:00GLOBEBriaCell to Present at the AACR 2022; Provides Corporate..